ResearcherNo recent work listed

Akio Hasegawa

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5109500036. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper

Papers 2

[Long-Term Survival in Response to Multimodality Therapy in a Patient with Invasive Pancreatic Cancer with Cyst Formation]. Co-author PMID 28133201 ↗
[R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1]. Last author PMID 26805123 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hisashi Kametaka · 2 shared papers, 2015–2016 · strength 0.13
- Paper [Long-Term Survival in Response to Multimodality Therapy in a Patient with Invasive Pancreatic Cancer with Cyst Formati… PMID 28133201 ↗
- Paper [R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1]. PMID 26805123 ↗
Kazuhiro Seike · 2 shared papers, 2015–2016 · strength 0.13
- Paper [Long-Term Survival in Response to Multimodality Therapy in a Patient with Invasive Pancreatic Cancer with Cyst Formati… PMID 28133201 ↗
- Paper [R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1]. PMID 26805123 ↗
Hironobu Makino · 2 shared papers, 2015–2016 · strength 0.13
- Paper [Long-Term Survival in Response to Multimodality Therapy in a Patient with Invasive Pancreatic Cancer with Cyst Formati… PMID 28133201 ↗
- Paper [R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1]. PMID 26805123 ↗
Masaru Isozaki · 1 shared paper, 2016 · strength 0.07
- Paper [Long-Term Survival in Response to Multimodality Therapy in a Patient with Invasive Pancreatic Cancer with Cyst Formati… PMID 28133201 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.